Expression of SHP2 and Related Markers in Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of SHP2 and Related Markers in Non–Small Cell Lung Cancer

Published:2013-10 Issue:5 Volume:21 Page:386-394
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Tang Chunlan,Luo Dan,Yang Heping,Wang Qingliang,Zhang Rong,Liu Guoxiang,Zhou Xiangdong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference7 articles.

1. Angiogenesis in non-small cell lung cancer.;DAmico;Semin Thorac Cardiovasc Surg,2004

2. The tyrosine phosphatase Shp2 (PTPN11) in cancer.;Chan;Cancer Metastasis Rev,2008

3. SHP2 mediates the localized activation of Fyn downstream of the alpha6beta4 integrin to promote carcinoma invasion.;Yang;Mol Cell Biol,2010

4. Increase in tissue inhibitor of metalloproteinase-2 (TIMP-2) levels and inhibition of MMP-2 activity in a metastatic breast cancer cell line by an anti-invasive small molecule SR13179.;Waleh;Cancer Lett,2010

5. VEGF-targeted therapy: mechanisms of anti-tumor activity.;Ellis;Nat Rev Cancer,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull’s eye for targeted therapy?;Frontiers in Immunology;2024-03-05

2. Mometasone furoate inhibits the progression of head and neck squamous cell carcinoma via regulating PTPN11;2023-02-22

3. Role of SHP2/PTPN11 in the occurrence and prognosis of cancer: A systematic review and meta‑analysis;Oncology Letters;2022-11-22

4. Hexachlorophene, a selective SHP2 inhibitor, suppresses proliferation and metastasis of KRAS-mutant NSCLC cells by inhibiting RAS/MEK/ERK and PI3K/AKT signaling pathways;Toxicology and Applied Pharmacology;2022-04

5. SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1-, or EGFR-altered Non–small Cell Lung Cancer;Molecular Cancer Therapeutics;2021-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3